0
Editorials: Point and Counterpoint |

Rebuttal From Dr Farber

Harold J. Farber, MD, MSPH, FCCP
Author and Funding Information

FINANCIAL/NONFINANCIAL DISCLOSURES: The author has reported to CHEST the following: H. J. F. serves as Associate Medical Director for Texas Children’s Health Plan, a not-for-profit Medicaid and CHIP managed care organization owned by Texas Children’s Hospital.

Pulmonary Section, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX

CORRESPONDENCE TO: Harold J. Farber, MD, MSPH, FCCP, Texas Children’s Hospital, Pulmonary Medicine Service, 6701 Fannin, Ste 1040.00, Houston, TX 77030


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(3):493. doi:10.1016/j.chest.2016.06.027
Text Size: A A A
Published online

Extract

Dr Weinberger asks what is loss of control? Are symptoms that need reliever medication a “full blown exacerbation”? Is the “yellow zone” simply a “procrastinator's zone”? Should we just cut to the chase and give oral corticosteroid medication any time a child has symptoms of asthma?

Is early initiation of oral corticosteroids by parents a good strategy? A clinical trial of 204 Medicaid-insured children with asthma 2 to 14 years of age in Baltimore, Maryland randomized participants to either prednisone or placebo for an attack that had not improved after a dose of the child's regular acute asthma medicine. They found a larger number of attacks resulting in ED visits in the group receiving prednisone and no difference in hospitalizations. Although the study assessments did not detect differences in side effects between the groups, it is possible that unmeasured side effects such as agitation or difficulty sleeping drove the parents to seek urgent/emergent medical attention. A clinical trial in the United Kingdom randomized 217 children 1 to 5 years with episodic wheezing associated with coryza to placebo or prednisolone for 5 days at onset of wheezing associated with coryza. There were no statistically significant differences in day or night symptom scores. Unexpectedly, the hospitalization rate was greater in the group receiving prednisolone (12% vs 3%), although the difference fell shy of the criteria for statistical significance (P = .06). Although oral corticosteroid medication has definite benefits for patients with a moderate to severe asthma exacerbation, these clinical trials suggest that for most patients, early initiation by parents is not beneficial.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
Management of asthma.
Singapore Ministry of Health | 7/18/2008
Adapting your practice: treatment and recommendations for homeless patients with asthma.
National Health Care for the Homeless Council, Inc. | 6/13/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543